VAERS reports by lot

Pfizer RSV lot HL9687: VAERS reports

26 VAERS reports list lot HL9687 as a Pfizer RSV vaccine, received between 2023-10-28 and 2024-10-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
26
Reports
12%
Marked serious
0
With a death outcome
8
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular717%
Respiratory614%
Injection-site / Local reaction614%
Musculoskeletal512%
Neurological410%
Dermatological (non-injection-site)410%
General / Systemic (non-local)410%
Gastrointestinal37%
Allergic / Anaphylactic25%
Autoimmune / Immune-mediated12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Ohio4
Michigan3
New York3
Maryland2
Washington2
Oklahoma1
Illinois1
Tennessee1
Maine1
North Carolina1
Virginia1
Kansas1

Reports by month received

2023-102
2023-115
2023-129
2024-013
2024-023
2024-031
2024-042
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.